What Sionna Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 5 | 147 |
| Total trades | 6 | 159 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 10,250 | 180,750 |
| Disposed | 413,774 | 4,139,445 |
| Net activity | −403,524 | −3,958,695 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Thompson Peter A | Director | Jul 07 | Disclosed 10b5-1 sale · S | −85,918 | $44.86 | −$3.85M | 2,469,959 |
| Orbimed Advisors Llc | Director | Jul 07 | Disclosed 10b5-1 sale · S | −85,918 | $44.86 | −$3.85M | 2,469,959 |
| Fitzpatrick Jennifer | Chief Legal Officer | Jul 06 | Open-market sale · S | −10,250 | $43.60 | −$447K | 0 |
| Fitzpatrick Jennifer | Chief Legal Officer | Jul 06 | Exercise / conversion · M | +10,250 | $6.11 | +$62.6K | 10,250 |
| Orbimed Advisors Llc | Director | Jun 30 | Disclosed 10b5-1 sale · S | −115,844 | $45.50 | −$5.27M | 2,555,877 |
| Thompson Peter A | Director | Jun 30 | Disclosed 10b5-1 sale · S | −115,844 | $45.50 | −$5.27M | 2,555,877 |
| Orbimed Advisors Llc | Director | May 27 | Disclosed 10b5-1 sale · S | −101 | $44.49 | −$4.49K | 2,671,721 |
| Thompson Peter A | Director | May 27 | Disclosed 10b5-1 sale · S | −101 | $44.49 | −$4.49K | 2,671,721 |
| Orbimed Advisors Llc | Director | May 11 | Disclosed 10b5-1 sale · S | −184,639 | $46.22 | −$8.53M | 2,671,822 |
| Thompson Peter A | Director | May 11 | Disclosed 10b5-1 sale · S | −184,639 | $46.22 | −$8.53M | 2,671,822 |
| Orbimed Advisors Llc | Director | May 08 | Disclosed 10b5-1 sale · S | −59,767 | $44.58 | −$2.66M | 2,856,461 |
| Thompson Peter A | Director | May 08 | Disclosed 10b5-1 sale · S | −59,767 | $44.58 | −$2.66M | 2,856,461 |
| Orbimed Advisors Llc | Director | May 07 | Disclosed 10b5-1 sale · S | −48,546 | $44.61 | −$2.17M | 2,916,228 |
| Thompson Peter A | Director | May 07 | Disclosed 10b5-1 sale · S | −48,546 | $44.61 | −$2.17M | 2,916,228 |
| Orbimed Advisors Llc | Director | Apr 18 | Disclosed 10b5-1 sale · S | −2,948 | $44.52 | −$131K | 2,964,774 |
| Thompson Peter A | Director | Apr 18 | Disclosed 10b5-1 sale · S | −2,948 | $44.52 | −$131K | 2,964,774 |
| Orbimed Advisors Llc | Director | Apr 17 | Disclosed 10b5-1 sale · S | −52,397 | $44.68 | −$2.34M | 2,967,722 |
| Thompson Peter A | Director | Apr 17 | Disclosed 10b5-1 sale · S | −52,397 | $44.68 | −$2.34M | 2,967,722 |
| Orbimed Advisors Llc | Director | Apr 16 | Disclosed 10b5-1 sale · S | −226,906 | $45.34 | −$10.3M | 3,020,119 |
| Thompson Peter A | Director | Apr 16 | Disclosed 10b5-1 sale · S | −226,906 | $45.34 | −$10.3M | 3,020,119 |
Loading...